Altre lingue BioHarvest Sciences Inc.

Azioni

BHSC

CA09076J1084

Mercato chiuso - Canadian Securities Exchange Altri mercati azionari 20:00:13 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,26 ^CAD	+1,96%		0,00%	+20,93%

16/04	BioHarvest Sciences Inc. annuncia il nuovo campus per il CDMO di sintesi botanica e l'espansione della capacità di produzione	CI
26/02	BioHarvest Sciences Inc. annuncia il lancio della nuova business unit Contract Development and Manufacturing Organization (Organizzazione di sviluppo e produzione a contratto)	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit	27/03
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables	21/03
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024	14/03
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit	13/03
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024	07/03
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time	29/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26/02
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm	20/02
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program	15/02
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference	12/02
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update	08/01
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement	27/12
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding	27/12
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th	14/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioHarvest Sciences Inc.

Azioni

BHSC

CA09076J1084

Altre lingue

Filtri